67 related articles for article (PubMed ID: 21358112)
1. Irinotecan as a maintenance therapy for hepatoblastoma: a comment.
Wiwanitkit V
J Cancer Res Ther; 2010; 6(4):588. PubMed ID: 21358112
[No Abstract] [Full Text] [Related]
2. Irinotecan as maintenance therapy in high-risk hepatoblastoma.
Qayed M; Powell C; Morgan ER; Haugen M; Katzenstein HM
Pediatr Blood Cancer; 2010 May; 54(5):761-3. PubMed ID: 20063426
[TBL] [Abstract][Full Text] [Related]
3. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
Palmer RD; Williams DM
Med Pediatr Oncol; 2003 Jul; 41(1):78-80. PubMed ID: 12764754
[No Abstract] [Full Text] [Related]
4. [Preliminary study on the efficacy of irinotecan in the treatment of childhood relapsed hepatoblastoma].
Chang J; Zhang YT; Zhong XD; Wang LZ
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):588-90. PubMed ID: 23866285
[No Abstract] [Full Text] [Related]
5. Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single-agent therapy with irinotecan.
Ijichi O; Ishikawa S; Shinkoda Y; Tanabe T; Okamoto Y; Takamatsu H; Inomata Y; Kawano Y
Pediatr Transplant; 2006 Aug; 10(5):635-8. PubMed ID: 16857004
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic approaches in the treatment of children with hepatoblastoma.
Katzenstein HM; Rigsby C; Shaw PH; Mitchell TL; Haut PR; Kletzel M
J Pediatr Hematol Oncol; 2002 Dec; 24(9):751-5. PubMed ID: 12468918
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and treatment of hepatoblastoma.
Feusner J
J Pediatr; 2006 Jan; 148(1):145. PubMed ID: 16423617
[No Abstract] [Full Text] [Related]
8. Central nervous system toxicity induced by irinotecan.
Hamberg P; Donders RC; ten Bokkel Huinink D
J Natl Cancer Inst; 2006 Feb; 98(3):219. PubMed ID: 16449682
[No Abstract] [Full Text] [Related]
9. Hepatoblastoma--a bit of a success story?
Shafford EA; Pritchard J
Eur J Cancer; 1994; 30A(8):1050-1. PubMed ID: 7654427
[No Abstract] [Full Text] [Related]
10. [Hepatic arterial infusion with irinotecan for the colorectal cancer patient with liver metastasis--a case report].
Yamaguchi T; Mori T; Takahashi K; Ohue M; Homma S; Arai K; Iwasaki Y; Kimura Y
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2370-2. PubMed ID: 12484077
[TBL] [Abstract][Full Text] [Related]
11. Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears.
Sullivan MJ
Cancer; 2009 Dec; 115(24):5623-6. PubMed ID: 19813276
[No Abstract] [Full Text] [Related]
12. Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study.
Dall'Igna P; Cecchetto G; Dominici C; Donfrancesco A; Carli M; Indolfi P; Guglielmi M; Perilongo G
Med Pediatr Oncol; 2001 Feb; 36(2):332-4. PubMed ID: 11452948
[No Abstract] [Full Text] [Related]
13. Docetaxel in the treatment of children with refractory or relapsed hepatoblastoma.
George SL; Broster S; Chisholm JC; Brock P
J Pediatr Hematol Oncol; 2012 Oct; 34(7):e295-7. PubMed ID: 22469940
[TBL] [Abstract][Full Text] [Related]
14. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Treatment of a Preterm Infant With Inoperable Congenital Hepatoblastoma--A Case Report.
Miura Y; Saito J; Shimanuki Y; Takeyama J; Murotsuki J
J Pediatr Hematol Oncol; 2015 Apr; 37(3):e188-90. PubMed ID: 24942027
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of multiple liver metastases of colon cancer with systemic irinotecan and hepatic arterial injection of 5-FU].
Nakamura Y; Kamigaki T; Tamura T; Kunimoto Y; Habara K; Fukumoto S; Iwasaki T; Nakamura T; Ku Y; Kuroda Y
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1772-5. PubMed ID: 11708031
[TBL] [Abstract][Full Text] [Related]
17. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.
Aliberti C; Tilli M; Benea G; Fiorentini G
Anticancer Res; 2006; 26(5B):3793-5. PubMed ID: 17094403
[TBL] [Abstract][Full Text] [Related]
18. Vincristine-associated neurological morbidity in the treatment of hepatoblastoma.
Lombardi AJ; Sutton ME; Tiao GM; Geller JI
J Pediatr Hematol Oncol; 2015 May; 37(4):e258-63. PubMed ID: 25757023
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic blastomatous tumor in a child responding to therapy used for hepatoblastoma: case report and review of the literature.
Morgan ER; Perryman JH; Reynolds M; Gonzalez-Crussi FJ
Med Pediatr Oncol; 1996 Apr; 26(4):284-92. PubMed ID: 8600344
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
